Dr. Robert L. Jobe, M.D.
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- University of North Carolina at Chapel Hill School of Medicine (1987)
- Years since graduation
- 39
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 710
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1987Medical school: University of North Carolina at Chapel Hill School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
NC license 36743 -
Cardiovascular Disease Physician
NC license 36743
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Rex Hospital Raleigh, NC
- Johnston Health Smithfield, NC
- Unc Health Care Wayne Goldsboro, NC
- Betsy Johnson Regional Hospital Dunn, NC
Medical groups
- North Carolina Mg LLC (751 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 710
- Services billed
- 3,434
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Injection, regadenoson, 0.1 mg | 428 | 107 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 265 | 254 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 265 | 133 |
| Anticoagulant management of patient taking warfarin | 206 | 54 |
| Established patient office or other outpatient visit, 30-39 minutes | 199 | 158 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 194 | 191 |
| Blood test, clotting time | 158 | 41 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 143 | 134 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 129 | 95 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 126 | 126 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Raleigh, NC | 548 |
| Isosorbide Mononitrate Er (isosorbide mononitrate) Other prescribers in Raleigh, NC | 349 |
| Atorvastatin Calcium Other prescribers in Raleigh, NC | 239 |
| Eliquis (apixaban) Other prescribers in Raleigh, NC | 231 |
| Losartan Potassium Other prescribers in Raleigh, NC | 202 |
| Metoprolol Succinate Other prescribers in Raleigh, NC | 150 |
| Spironolactone Other prescribers in Raleigh, NC | 145 |
| Ranolazine Er (ranolazine) Other prescribers in Raleigh, NC | 138 |
| Carvedilol Other prescribers in Raleigh, NC | 131 |
| Furosemide Other prescribers in Raleigh, NC | 114 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 17 companies reported 56 payments worth $23,509 in total to this clinician.
| Shockwave Medical, Inc | $13,625 |
|---|---|
| Chiesi USA, Inc. | $7,280 |
| Medtronic, Inc. | $1,212 |
| Boston Scientific Corporation | $544 |
| Abbott Laboratories | $215 |
| Abiomed | $184 |
| Cordis US Corp. | $183 |
| Cardiva Medical, Inc. | $78.41 |
| Consulting Fee | $20,480 |
|---|---|
| Food and Beverage | $2,132 |
| Travel and Lodging | $897 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Chiesi USA, Inc. Dec 4, 2025 | Consulting Fee | $7,280 |
| Shockwave Medical, Inc Mar 20, 2025 | Consulting Fee Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Cardiology | $4,400 |
| Shockwave Medical, Inc Dec 19, 2025 | Consulting Fee Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Cardiology | $4,400 |
| Shockwave Medical, Inc Jun 13, 2025 | Consulting Fee Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Cardiology | $4,400 |
| Medtronic, Inc. Jun 11, 2025 | Travel and Lodging SYMPLICITY G3 · Renal Denervation System · travel to Boston, MA · in-kind | $496 |
| Medtronic, Inc. Jul 13, 2025 | Travel and Lodging SYMPLICITY G3 · Renal Denervation System · travel to Boston, MA · in-kind | $290 |
| Medtronic, Inc. Jul 13, 2025 | Travel and Lodging SYMPLICITY G3 · Renal Denervation System · travel to Boston, MA · in-kind | $47.71 |
| Medtronic, Inc. Jun 11, 2025 | Travel and Lodging SYMPLICITY G3 · Renal Denervation System · travel to Boston, MA · in-kind | $35.07 |
| Medtronic, Inc. Jul 14, 2025 | Travel and Lodging SYMPLICITY G3 · Renal Denervation System · travel to Boston, MA · in-kind | $14.22 |
| Medtronic, Inc. Jul 14, 2025 | Travel and Lodging SYMPLICITY G3 · Renal Denervation System · travel to Boston, MA · in-kind | $14.09 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $3,482 in research payments for these studies, mostly to the institutions running them.
- Early-TAVR Trial #2016-07
Edwards Lifesciences Corporation - Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting
Philips North America LLC · Enrolling by invitation · NCT04451044
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.